Polar Capital Holdings’s Cogent Biosciences COGT Stock Holding History

Polar Capital Holdings’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,228,828	Closed	-$10.3K	–	450
2021 Q3	$10.3K	Buy	1,228,828 +228,828	+23%	+$1.75M	0.04%	228
2021 Q2	$8.11K	Hold	1,000,000	–	–	0.04%	246
2021 Q1	$8.78M	Sell	1,000,000 -189,900	-16%	-$1.83M	0.05%	219
2020 Q4	$13.4M	Buy	+1,189,900	New	+$13.1M	0.08%	187

Other funds holding COGT

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Polar Capital Holdings's COGT Position: Q4 2021 in Review

Polar Capital Holdings sold out of Cogent Biosciences (COGT) in Q4 2021, closing a stake of 1,228,828 shares — an estimated $10.3K sold.

Polar Capital Holdings first reported a position in COGT in Q4 2020 and held it in 4 quarters. The position peaked at $13.4M in Q4 2020. 82 funds tracked by Wall St. Rank hold COGT as of Q4 2021.

Polar Capital Holdings reported no remaining Cogent Biosciences position as of Q4 2021 after selling out during the quarter.
Polar Capital Holdings sold 1,228,828 Cogent Biosciences shares in Q4 2021, an estimated $10.3K.
Polar Capital Holdings first reported a position in Cogent Biosciences in Q4 2020 and held it in 4 quarters.
Polar Capital Holdings's Cogent Biosciences position peaked at $13.4M in Q4 2020.
82 funds tracked by Wall St. Rank held Cogent Biosciences as of Q4 2021.

Based on Polar Capital Holdings's 13F filing for Q4 2021, filed 14 Feb 2022.